Invasive Pneumococcal Disease in Tuscany Region, Italy, 2016–2017: Integrating Multiple Data Sources to Investigate Underreporting

Invasive Pneumococcal Disease in Tuscany Region, Italy, 2016–2017: Integrating Multiple Data Sources to Investigate Underreporting

Invasive pneumococcal disease (IPD) is a vaccine-preventable disease characterized by the presence of <i>Streptococcus pneumoniae</i> in normally sterile sites. Since 2007, Italy has implemented an IPD national surveillance system (IPD-NSS). This system suffers from high rates of underre...

Full description

Bibliographic Details
Main Authors:	Filippo Quattrone, Gabriele Donzelli, Sara D’Arienzo, Marco Fornili, Francesco Innocenti, Silvia Forni, Laura Baglietto, Lara Tavoschi, Pier Luigi Lopalco
Format:	Article
Language:	English
Published:	MDPI AG 2020-10-01
Series:	International Journal of Environmental Research and Public Health
Subjects:	invasive pneumococcal disease surveillance systems evaluation vaccine-preventable diseases capture–recapture analysis
Online Access:	https://www.mdpi.com/1660-4601/17/20/7581

Similar Items

Underreporting of Human Alveolar Echinococcosis, Germany
by: Pernille Jorgensen, et al.
Published: (2008-06-01)

Risk Factors for Death from Invasive Pneumococcal Disease, Europe, 2010
by: Adoración Navarro-Torné, et al.
Published: (2015-03-01)

Evolution, Clinical and Microbiological Characteristics of Invasive Pneumococcal Disease since the Introduction of the Pneumococcal Conjugate Vaccine 13-Valent in Adults over 18 Years Old
by: Juan Buades, et al.
Published: (2021-01-01)

Efficacy of pneumococcal vaccine in immunocompetent and immunocompromised patients
by: M. P. Kostinov, et al.
Published: (2019-11-01)

EFFECTIVENESS OF THE 13-VALENT PNEUMOCOCCAL CONJUGATE VACCINE: EMERGING DATA FROM INVASIVE PNEUMOCOCCAL DISEASE, PNEUMONIA, ACUTE OTITIS MEDIA AND NASOPHARYNGEAL CARRIAGE
by: Ralf Rene Reinert, et al.
Published: (2012-06-01)

Record linkage and capture-recapture estimates for underreporting of human leptospirosis in a Brazilian health district
by: Liane Brum, et al.

Pneumococcal meningitis: epidemiological profile pre‐ and post‐introduction of the pneumococcal 10‐valent conjugate vaccine
by: Tatiane E. Hirose, et al.
Published: (2015-03-01)

Towards the mother-of-all-models: customised construction of the mark-recapture likelihood function
by: Barker, R. J., et al.
Published: (2004-05-01)

Pneumococcal Serogroups Causing the Most of the Invasive Diseases in Kayseri
by: Duygu EŞEL, et al.
Published: (2002-03-01)

Parental knowledge, attitudes and perception of pneumococcal disease and pneumococcal conjugate vaccines in Singapore: a questionnaire-based assessment
by: Choon How How, et al.
Published: (2016-09-01)

Pneumococcal vaccine uptake and vaccine effectiveness in older adults with invasive pneumococcal disease in Germany: A retrospective cohort study
by: Stephanie Perniciaro, et al.
Published: (2021-08-01)

Global Landscape Review of Serotype-Specific Invasive Pneumococcal Disease Surveillance among Countries Using PCV10/13: The Pneumococcal Serotype Replacement and Distribution Estimation (PSERENADE) Project
by: Maria Deloria Knoll, et al.
Published: (2021-04-01)

Fungal infection has sublethal effects in a lowland subtropical amphibian population
by: Laura A. Brannelly, et al.
Published: (2018-09-01)

Evolution of pneumococcal infections in adult patients during a four-year period after vaccination of a pediatric population with 13-valent pneumococcal conjugate vaccine
by: Antoni Payeras, et al.
Published: (2015-04-01)

Invasive pneumococcal disease in persons with predisposing factors is dominated by non-vaccine serotypes in Southwest Sweden
by: Karin Bergman, et al.
Published: (2021-08-01)

A Systematic Review of Studies Published between 2016 and 2019 on the Effectiveness and Efficacy of Pneumococcal Vaccination on Pneumonia and Invasive Pneumococcal Disease in an Elderly Population
by: Jacob Dag Berild, et al.
Published: (2020-04-01)

Invasive pneumococcal disease in children with cancer: Incidence density, risk factors and isolated serotypes
by: Pedro Mendes Lages, et al.
Published: (2020-11-01)

Pneumococcal disease in Thailand
by: Amgad Gamil, et al.
Published: (2021-01-01)

The remaining challenges of pneumococcal disease in adults
by: E. Ludwig, et al.
Published: (2012-03-01)

Childhood invasive pneumococcal disease caused by non-7-valent pneumococcal vaccine (PCV7) serotypes under partial immunization in Taiwan
by: Ching-Fen Shen, et al.
Published: (2013-09-01)

Effectiveness of 13-pneumococcal conjugate vaccine (PCV13) against invasive pneumococcal disease in children in the Dominican Republic
by: Sara Tomczyk, et al.
Published: (2018-04-01)

NEXT GENERATION PNEUMOCOCCAL CONJUGATE VACCINES EFFICACY AND EFFECTIVENESS IN DIFFERENT REGIONS OF THE WORLD
by: O. P. Kovtun, et al.
Published: (2014-01-01)

Immunochromatographic method in the diagnosis of pneumococcal respiratory tract diseases
by: V. V. Nikolenko, et al.
Published: (2014-09-01)

Pneumococcal Disease is a Feasible Problem
by: L.I. Chernyshova
Published: (2013-04-01)

Les méthodes de capture-recapture pour évaluer les systèmes de surveillance des maladies animales
by: Vergne, Timothée
Published: (2012)

Gastrointestinal symptoms in invasive pneumococcal disease: a cohort study
by: Hans Kristian Floeystad, et al.
Published: (2020-07-01)

Pediatric Pneumococcal Serotypes in 4 European Countries
by: Germaine Hanquet, et al.
Published: (2010-09-01)

Twenty-Year Public Health Impact of 7- and 13-Valent Pneumococcal Conjugate Vaccines in US Children
by: Matt Wasserman, et al.
Published: (2021-06-01)

Pneumococcal serotypes associated with invasive disease in under five children in India & implications for vaccine policy
by: V Balaji, et al.
Published: (2015-01-01)

Changes in invasive pneumococcal disease serotypes in a regional area of Australia following three years of 7vPCV introduction
by: Fakhrul Islam, et al.
Published: (2012-06-01)

Invasive pneumococcal disease among children younger than 5 years of age before and after introduction of pneumococcal conjugate vaccine in Casablanca, Morocco
by: Idrissa Diawara, et al.
Published: (2015-11-01)

Increased Invasive Pneumococcal Disease, North East England, UK
by: Catherine Houseman, et al.
Published: (2017-01-01)

Cost-effectiveness of 2 + 1 dosing of 13-valent and 10-valent pneumococcal conjugate vaccines in Canada
by: Earnshaw Stephanie R, et al.
Published: (2012-04-01)

Effectiveness of pneumococcal conjugate vaccination against invasive pneumococcal disease among children with and those without HIV infection: a systematic review and meta-analysis
by: Hossein Molavi Vardanjani, et al.
Published: (2019-08-01)

Leveraging Partial Identity Information in Spatial Capture-Recapture Studies with Applications to Remote Camera and Genetic Capture-Recapture Surveys
by: Augustine, Ben C.
Published: (2018)

Pneumococcal conjugate 7-valent vacciPNEUMOCOCCAL CONJUGATE 7-VALENT VACCINE IN CHILDREN. REGIONAL EXPERIENCEne in children. Regional experience
by: N. L. Chernaya, et al.
Published: (2012-02-01)

Immunogenicity of pneumococcal vaccination in HIV infected individuals: A systematic review and meta-analysis
by: Hannah M.Garcia Garrido, et al.
Published: (2020-12-01)

Bronchopulmonary Pathology Prevalence Among Premature infants and Estimation of Prophylactic Efficacy and Reactogenicity of 13-Valent Pneumococcal Conjugate Vaccine in Premature infants with Bronchopulmonary Dysplasia
by: Vladislav V. Semerikov, et al.
Published: (2020-02-01)

The Risk of Invasive Pneumococcal Disease Differs between Risk Groups in Norway Following Widespread Use of the 13-Valent Pneumococcal Vaccine in Children
by: Brita Askeland Winje, et al.
Published: (2021-08-01)

The Analysis of Scientific Data on the Efficacy of Pneumococcal Conjugated Vaccine in the Cohort of Children with Bronchial Asthma
by: Tatiana A. Kaliuzhnaia, et al.
Published: (2020-11-01)

Cannot write session to /tmp/vufind_sessions/sess_gv4jdus4hbb55dfcqsvvluaf1n